aerie pharmaceuticals using rock inhibitors to change glaucoma management (ois@aao 2016)
Published 7 years ago • 2.3K plays • Length 8:59Download video MP4
Download video MP3
Similar videos
-
6:26
aerie pharmaceuticals: moving beyond glaucoma (ois@asrs 2016)
-
10:10
aerie pharmaceuticals - ois@aao 2015
-
8:30
inotek “transforming glaucoma treatments” (ois@aao 2016)
-
5:28
aerie pharmaceuticals - ois@ascrs 2015
-
5:27
clinical progress of aerie pharmaceuticals’ rhopressa and roclatan
-
7:57
aerie: bringing rhopressa and roclatan into us glaucoma marke
-
9:01
aerie pharmaceuticals - public company showcase at ophthalmology innovation summit @ asrs 2019
-
6:32
aerie looks for rhopressa nda in q3
-
7:34
aerie pharmaceuticals - ois@ascrs (2018)
-
8:02
aerie pharmaceuticals - innovation showcase at ophthalmology innovation summit @ ascrs 2019
-
7:18
envisia therapeutics: overcoming compliance issues in glaucoma (ois@aao 2016)
-
6:57
ois q&a with aerie’s tom mitro: “if you really care about what you do, you can make it the best.”
-
7:13
aerie pharmaceuticals
-
6:54
aerie pharmaceuticals reports strong progress in retinal program
-
14:58
catch up on ois@aao’s year in review (ois@aao 2016)
-
27:41
glaucoma breakout at ophthalmology innovation summit @ aao 2019
-
8:21
david a. hollander, md, mba - aerie pharmaceuticals
-
5:07
aerie coo mitro provides staffing, pipeline update
-
8:05
adverum biotechnologies gains momentum in gene therapy (ois@aao 2016)